Cargando…

Management and outcome of vagus nerve stimulator implantation: experience of an otolaryngeal/neuropediatric cooperation

OBJECTIVE: Vagus nerve stimulator (VNS) implantation is an established therapy for pharmacoresistant epilepsy that is not amenable to curative epilepsy surgery. Historically, VNS implantation has been performed by neurosurgeons, but otolaryngologist involvement is increasingly common. In this retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Grasl, S., Janik, S., Dressler, A., Diehm, R., Gröppel, G., Eichinger, K., Grasl, M. C., Gstoettner, W., Feucht, M., Vyskocil, E., Baumgartner, W. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382619/
https://www.ncbi.nlm.nih.gov/pubmed/34196736
http://dx.doi.org/10.1007/s00405-021-06943-x
_version_ 1783741571230859264
author Grasl, S.
Janik, S.
Dressler, A.
Diehm, R.
Gröppel, G.
Eichinger, K.
Grasl, M. C.
Gstoettner, W.
Feucht, M.
Vyskocil, E.
Baumgartner, W. D.
author_facet Grasl, S.
Janik, S.
Dressler, A.
Diehm, R.
Gröppel, G.
Eichinger, K.
Grasl, M. C.
Gstoettner, W.
Feucht, M.
Vyskocil, E.
Baumgartner, W. D.
author_sort Grasl, S.
collection PubMed
description OBJECTIVE: Vagus nerve stimulator (VNS) implantation is an established therapy for pharmacoresistant epilepsy that is not amenable to curative epilepsy surgery. Historically, VNS implantation has been performed by neurosurgeons, but otolaryngologist involvement is increasingly common. In this retrospective study, we aimed to evaluate the efficacy and safety of VNS implantation in children and adolescents from the otolaryngologists’ perspective. METHODS: This study included children and adolescents who had undergone VNS implantation at the study center between 2014 and 2018. Patient files were analyzed with regards to the durations of device implantation and hospitalization, postoperative complications, and clinical outcome, including seizure frequency, clinical global impression of improvement (CGI-I) score, and quality of life (QoL). RESULTS: A total of 73 children underwent VNS surgery. The median age at implantation was 9.3 ± 4.6 years, and median epilepsy duration before VNS surgery was 6 ± 4 years. Lennox–Gastaut syndrome was the most common syndrome diagnosis (62.3%), and structural abnormalities (49.3%) the most frequent etiology. Operation times ranged from 30 to 200 min, and median postoperative hospitalization length was 2 ± 0.9 days. No complications occurred, except for four revisions and two explantations due to local infections (2.7%). Among our patients, 76.7% were responders (≥ 50% reduction in seizure frequency), 72.1% showed improved CGI-I scores, and 18.6–60.5% exhibited considerable improvements in the QoL categories energy, emotional health, and cognitive functions. CONCLUSION: Our results indicate that VNS implantation is a highly effective and safe treatment option for children and adolescents with AED-refractory epilepsies who are not candidates for curative epilepsy surgery. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00405-021-06943-x.
format Online
Article
Text
id pubmed-8382619
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-83826192021-09-09 Management and outcome of vagus nerve stimulator implantation: experience of an otolaryngeal/neuropediatric cooperation Grasl, S. Janik, S. Dressler, A. Diehm, R. Gröppel, G. Eichinger, K. Grasl, M. C. Gstoettner, W. Feucht, M. Vyskocil, E. Baumgartner, W. D. Eur Arch Otorhinolaryngol Laryngology OBJECTIVE: Vagus nerve stimulator (VNS) implantation is an established therapy for pharmacoresistant epilepsy that is not amenable to curative epilepsy surgery. Historically, VNS implantation has been performed by neurosurgeons, but otolaryngologist involvement is increasingly common. In this retrospective study, we aimed to evaluate the efficacy and safety of VNS implantation in children and adolescents from the otolaryngologists’ perspective. METHODS: This study included children and adolescents who had undergone VNS implantation at the study center between 2014 and 2018. Patient files were analyzed with regards to the durations of device implantation and hospitalization, postoperative complications, and clinical outcome, including seizure frequency, clinical global impression of improvement (CGI-I) score, and quality of life (QoL). RESULTS: A total of 73 children underwent VNS surgery. The median age at implantation was 9.3 ± 4.6 years, and median epilepsy duration before VNS surgery was 6 ± 4 years. Lennox–Gastaut syndrome was the most common syndrome diagnosis (62.3%), and structural abnormalities (49.3%) the most frequent etiology. Operation times ranged from 30 to 200 min, and median postoperative hospitalization length was 2 ± 0.9 days. No complications occurred, except for four revisions and two explantations due to local infections (2.7%). Among our patients, 76.7% were responders (≥ 50% reduction in seizure frequency), 72.1% showed improved CGI-I scores, and 18.6–60.5% exhibited considerable improvements in the QoL categories energy, emotional health, and cognitive functions. CONCLUSION: Our results indicate that VNS implantation is a highly effective and safe treatment option for children and adolescents with AED-refractory epilepsies who are not candidates for curative epilepsy surgery. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00405-021-06943-x. Springer Berlin Heidelberg 2021-07-01 2021 /pmc/articles/PMC8382619/ /pubmed/34196736 http://dx.doi.org/10.1007/s00405-021-06943-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Laryngology
Grasl, S.
Janik, S.
Dressler, A.
Diehm, R.
Gröppel, G.
Eichinger, K.
Grasl, M. C.
Gstoettner, W.
Feucht, M.
Vyskocil, E.
Baumgartner, W. D.
Management and outcome of vagus nerve stimulator implantation: experience of an otolaryngeal/neuropediatric cooperation
title Management and outcome of vagus nerve stimulator implantation: experience of an otolaryngeal/neuropediatric cooperation
title_full Management and outcome of vagus nerve stimulator implantation: experience of an otolaryngeal/neuropediatric cooperation
title_fullStr Management and outcome of vagus nerve stimulator implantation: experience of an otolaryngeal/neuropediatric cooperation
title_full_unstemmed Management and outcome of vagus nerve stimulator implantation: experience of an otolaryngeal/neuropediatric cooperation
title_short Management and outcome of vagus nerve stimulator implantation: experience of an otolaryngeal/neuropediatric cooperation
title_sort management and outcome of vagus nerve stimulator implantation: experience of an otolaryngeal/neuropediatric cooperation
topic Laryngology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382619/
https://www.ncbi.nlm.nih.gov/pubmed/34196736
http://dx.doi.org/10.1007/s00405-021-06943-x
work_keys_str_mv AT grasls managementandoutcomeofvagusnervestimulatorimplantationexperienceofanotolaryngealneuropediatriccooperation
AT janiks managementandoutcomeofvagusnervestimulatorimplantationexperienceofanotolaryngealneuropediatriccooperation
AT dresslera managementandoutcomeofvagusnervestimulatorimplantationexperienceofanotolaryngealneuropediatriccooperation
AT diehmr managementandoutcomeofvagusnervestimulatorimplantationexperienceofanotolaryngealneuropediatriccooperation
AT groppelg managementandoutcomeofvagusnervestimulatorimplantationexperienceofanotolaryngealneuropediatriccooperation
AT eichingerk managementandoutcomeofvagusnervestimulatorimplantationexperienceofanotolaryngealneuropediatriccooperation
AT graslmc managementandoutcomeofvagusnervestimulatorimplantationexperienceofanotolaryngealneuropediatriccooperation
AT gstoettnerw managementandoutcomeofvagusnervestimulatorimplantationexperienceofanotolaryngealneuropediatriccooperation
AT feuchtm managementandoutcomeofvagusnervestimulatorimplantationexperienceofanotolaryngealneuropediatriccooperation
AT vyskocile managementandoutcomeofvagusnervestimulatorimplantationexperienceofanotolaryngealneuropediatriccooperation
AT baumgartnerwd managementandoutcomeofvagusnervestimulatorimplantationexperienceofanotolaryngealneuropediatriccooperation